The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl-5-(2-(benzo[d]oxazol-2-ylamino)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyrimidine-5-carboxamido)nicotinate ID: ALA5081596
PubChem CID: 156898881
Max Phase: Preclinical
Molecular Formula: C26H21ClN6O4
Molecular Weight: 516.95
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)c1cncc(NC(=O)C2=C(C)NC(Nc3nc4ccccc4o3)=NC2c2ccccc2Cl)c1
Standard InChI: InChI=1S/C26H21ClN6O4/c1-14-21(23(34)30-16-11-15(12-28-13-16)24(35)36-2)22(17-7-3-4-8-18(17)27)32-25(29-14)33-26-31-19-9-5-6-10-20(19)37-26/h3-13,22H,1-2H3,(H,30,34)(H2,29,31,32,33)
Standard InChI Key: SQNMMBITUZVTCB-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
30.7058 -12.8395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6923 -13.4247 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
30.7058 -11.6646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7192 -11.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7287 -11.6640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7287 -12.8343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7217 -13.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7217 -14.5886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7352 -15.1737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7487 -14.5885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7621 -15.1737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7756 -14.5886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7760 -13.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7871 -12.8359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.8008 -13.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8030 -14.5858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7934 -15.1764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8164 -15.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8299 -14.5858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.8434 -15.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8164 -16.3412 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.7487 -13.4183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7352 -16.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7486 -16.9290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7217 -16.9290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7082 -16.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6947 -16.9291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6812 -16.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5590 -15.1807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4148 -14.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8271 -13.9204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6582 -13.9204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0786 -14.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6639 -15.9505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8299 -15.9505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6127 -16.8197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.7082 -15.1737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 1 1 0
4 3 2 0
5 4 1 0
6 5 2 0
7 6 1 0
1 7 2 0
8 7 1 0
8 9 1 0
9 10 1 0
10 11 1 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
16 18 1 0
18 19 1 0
19 20 1 0
18 21 2 0
10 22 2 0
23 9 2 0
23 24 1 0
25 23 1 0
26 25 1 0
26 27 1 0
27 28 1 0
29 28 2 0
30 29 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
35 34 1 0
35 30 2 0
36 35 1 0
36 28 1 0
37 26 2 0
37 8 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 516.95Molecular Weight (Monoisotopic): 516.1313AlogP: 4.69#Rotatable Bonds: 5Polar Surface Area: 130.74Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.61CX Basic pKa: 3.61CX LogP: 3.72CX LogD: 3.72Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.33Np Likeness Score: -1.19
References 1. (2021) Galactokinase inhibitors,